Nicotinic receptor abnormalities in Alzheimer’s disease
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 49 (3) , 175-184
- https://doi.org/10.1016/s0006-3223(00)01116-1
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Clinical neurochemistry: developments in dementia research based on brain bank materialJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Correlation of nicotinic binding with neurochemical markers in Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Age-related changes in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human frontal cortex and hippocampusNeuroscience Letters, 1998
- Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brainsNeuroReport, 1995
- Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapiesLife Sciences, 1995
- Kinetic Analysis of Regional (S)(-)11C-Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission TomographyAlzheimer Disease & Associated Disorders, 1995
- Smoking and Alzheimer's Disease: A Review of the Epidemiological EvidenceNeuroepidemiology, 1994
- Autoradiographic distribution of [3H]nicotine binding in human cortex: Relative abundance in subicular complexJournal of Chemical Neuroanatomy, 1992
- Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularisJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholineNeuropharmacology, 1989